HIV/AIDS continues to be a significant global health challenge, necessitating advanced strategies in Infectious Diseases, Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session covers the latest in antiretroviral therapy, breakthrough research in vaccine development, and innovative prevention programs. Participants will explore the global burden of HIV, emerging trends in high-risk populations, and evidence-based approaches to reduce transmission.
The session also highlights the role of Antimicrobial Resistance (AMR) in co-infections among HIV patients, addressing treatment challenges and public health implications. By combining research insights with practical public health interventions, attendees will learn to implement holistic strategies that optimize patient outcomes, prevent new infections, and strengthen community health programs.
Key Highlights
Why This Session Is Important?
Staying abreast of HIV/AIDS research is critical for reducing transmission and improving patient outcomes. This session equips participants with strategies to enhance treatment, prevention, and public health impact globally.